XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segment Information | 6 Months Ended
--- | ---
Jun. 29, 2018
Segment Reporting [Abstract] |
SEGMENT INFORMATION | SEGMENT INFORMATION The Company organizes its business into two reportable segments: (1) Medical and (2) Non-Medical. This segment structure reflects the financial information and reports used by the Company’s management, specifically its Chief Operating Decision Maker (“CODM”), to make decisions regarding the Company’s business, including resource allocations and performance assessments. This segment structure reflects the Company’s current operating focus in compliance with ASC 280, Segment Reporting. There were no sales between segments during the six months ended June 29, 2018 and June 30, 2017. The following table presents sales from continuing operations by product line (in thousands).
| Three Months Ended |  | Six Months Ended
| June 29, 2018 |  | June 30, 2017 |  | June 29, 2018 |  | June 30, 2017
Segment sales from continuing operations by product line: |  |  |  |  |  |
Medical |  |  |  |  |  |  |
Cardio & Vascular | $ | 148,766 |  |  | $ | 130,718 |  |  | $ | 285,629 |  |  | $ | 254,202 |
Cardiac & Neuromodulation | 115,941 |  |  | 106,173 |  |  | 224,851 |  |  | 209,928 |
Advanced Surgical, Orthopedics & Portable Medical | 34,751 |  |  | 28,282 |  |  | 68,692 |  |  | 56,433 |
Total Medical | 299,458 |  |  | 265,173 |  |  | 579,172 |  |  | 520,563 |
Non-Medical | 15,006 |  |  | 15,743 |  |  | 27,718 |  |  | 27,089 |
Total sales from continuing operations | $ | 314,464 |  |  | $ | 280,916 |  |  | $ | 606,890 |  |  | $ | 547,652 |
The following table presents income from continuing operations for the Company’s reportable segments (in thousands).
| Three Months Ended |  | Six Months Ended
| June 29, 2018 |  | June 30, 2017 |  | June 29, 2018 |  | June 30, 2017
Segment income from continuing operations: |  |  |  |  |  |  |
Medical | $ | 61,179 |  |  | $ | 51,557 |  |  | $ | 108,694 |  |  | $ | 99,274 |
Non-Medical | 4,393 |  |  | 4,940 |  |  | 7,591 |  |  | 6,502 |
Total segment income from continuing operations | 65,572 |  |  | 56,497 |  |  | 116,285 |  |  | 105,776 |
Unallocated operating expenses | (21,214 | ) |  | (20,435 | ) |  | (41,884 | ) |  | (45,811 | )
Operating income from continuing operations | 44,358 |  |  | 36,062 |  |  | 74,401 |  |  | 59,965 |
Unallocated expenses, net | (12,563 | ) |  | (26,248 | ) |  | (24,148 | ) |  | (46,414 | )
Income before taxes from continuing operations | $ | 31,795 |  |  | $ | 9,814 |  |  | $ | 50,253 |  |  | $ | 13,551 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration